Our Experience

Da Vinci Study – Amgen​

Registry with 1 year retrospective data collection from a cross-sectional cohort of CHD/PVD/PP/Stroke patients ​

Aim: to estimate the proportion of patients in Europe with an LDL-C above 2016 ESC guidelines​

  • 18 countries​
  • 6000 Patients ​
  • 132 investigator sites ​
  • Full service delivery in-house at ICTU​
  • 2.5 years from setup – archiving​
  • 18 month recruitment period​

Results: Among patients receiving LLT fewer than half of high/very high-risk primary and secondary prevention patients achieved 2016 LDL-C goals, with approximately one-fifth achieving the lower 2019 goals​


For further information regarding our services and how we can collaborate, please contact our team